XML 24 R13.htm IDEA: XBRL DOCUMENT v3.7.0.1
Equity
3 Months Ended
Mar. 31, 2017
Equity [Abstract]  
Equity
Equity

At-the-Market Program

On March 2, 2016, we commenced an “at-the-market” equity distribution program pursuant to which we may issue and sell common units for up to $300.0 million in gross proceeds. This program is registered with the SEC on an effective registration statement on Form S-3. On February 28, 2017, we entered into an Amended and Restated Equity Distribution Agreement with the Managers named therein.

During the quarter ended March 31, 2016, we completed the sale of 750,000 common units under this program for $25.4 million net proceeds ($25.5 million gross proceeds, or an average price of $34.00 per common unit, less $0.1 million of transaction fees). In connection with the issuance of the common units, we issued 15,307 general partner units to our general partner for $0.5 million in order to maintain its 2.0% general partner interest in us. We used the net proceeds from these sales of common units and from our general partner’s proportionate capital contribution to repay borrowings outstanding under the Five Year Revolver and the 364-Day Revolver and for general partnership purposes.

During the quarter ended March 31, 2017, we did not sell any common units under this program.
 
Public Offering
 
On March 29, 2016, we completed the sale of 12,650,000 common units in a registered public offering (the "March 2016 Offering") for $395.1 million net proceeds ($401.6 million gross proceeds, or $31.75 per common unit, less $6.3 million of underwriter's fees and $0.2 million of transaction fees). In connection with the issuance of the common units, we issued 258,163 general partner units to our general partner for $8.2 million in order to maintain its 2.0% general partner interest in us. We used the net proceeds from the March 2016 Offering and from our general partner’s proportionate capital contribution to repay borrowings outstanding under the Five Year Revolver and the 364-Day Revolver and for general partnership purposes.

Units Outstanding

As of March 31, 2017, we had 177,317,444 common units outstanding, of which 88,367,308 were publicly owned. SPLC owned 88,950,136 common units, representing an aggregate 49.2% limited partner interest in us, all of the incentive distribution rights, and 3,618,723 general partner units, representing a 2.0% general partner interest in us.

The changes in the number of units outstanding from December 31, 2016 through March 31, 2017 are as follows:
 
 
 
Public
 
SPLC
 
SPLC
 
General
 
 
(in units)
 
Common
 
Common
 
Subordinated
 
Partner
 
Total
Balance as of December 31, 2016
 
88,367,308

 
21,475,068

 
67,475,068

 
3,618,723

 
180,936,167

Expiration of subordination period
 

 
67,475,068

 
(67,475,068
)
 

 

Balance as of March 31, 2017
 
88,367,308

 
88,950,136

 

 
3,618,723

 
180,936,167


Expiration of Subordination Period

On February 15, 2017, all of the subordinated units converted into common units following the payment of the cash distribution for the fourth quarter of 2016. Each of our 67,475,068 outstanding subordinated units converted into one common unit. As of March 31, 2017, and for any distribution of available cash in the 2017 periods, the converted units will participate pro rata with the other common units in distributions of available cash. The conversion of the subordinated units does not impact the amount of cash distributions paid by us or the total number of outstanding units. The allocation of net income and cash distributions during the period were effected in accordance with terms of the partnership agreement.

Distributions to our Unitholders

The following table details the distributions declared and/or paid for the periods presented:

Date Paid or
 
 
 
Public
 
SPLC
 
SPLC
 
General Partner
 
 
 
Distributions
per Limited
Partner Unit
to be Paid
 
Three Months Ended
 
Common
 
Common
 
Subordinated
 
IDR's
 
2%
 
Total
 
 
 
 
 
(in millions, except per unit amounts)
February 11, 2016
 
December 31, 2015
 
$
13.8

 
$
4.7

 
$
14.9

 
$
1.2

 
$
0.7

 
$
35.3

 
$
0.22000

May 12, 2016
 
March 31, 2016
 
17.9

 
5.1

 
15.8

 
2.0

 
0.9

 
41.7

 
0.23500

August 12, 2016
 
June 30, 2016
 
22.0

 
5.4

 
16.9

 
3.7

 
1.0

 
49.0

 
0.25000

November 14, 2016
 
September 30, 2016
 
23.3

 
5.7

 
17.8

 
6.0

 
1.1

 
53.9

 
0.26375

February 14, 2017
 
December 31, 2016
 
24.5

 
5.9

 
18.7

 
8.3

 
1.2

 
58.6

 
0.27700

May 12, 2017
 
March 31, 2017 (1)
 
25.7

 
25.9

 

 
10.7

 
1.3

 
63.6

 
0.29100

 
(1) For more information see Note 11 Subsequent Events.


Distributions to Noncontrolling Interest

Distributions to SPLC for its noncontrolling interest in Zydeco were $3.2 million and $12.4 million, respectively, for the three months ended March 31, 2017 and 2016. See Note 2—Related Party Transactions for additional details.